Valneva SE (VALN) Operating Expenses (2021 - 2026)

Valneva SE's (VALN) quarterly Operating Expenses came in at -$27.4 million in Q1 2026, down 8.82% year-on-year from -$30.0 million in Q1 2025, and down 111.1% quarter-over-quarter from $246.6 million in Q4 2025.

Valneva SE (VALN) Operating Expenses (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Operating Expenses across 6 years of filings, most recently posting -$27.4 million for Q1 2026.

  • Operating Expenses for Q1 2026 came in at -$27.4 million, down 8.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $143.9 million (up 15.9% YoY), and the FY2025 annual result was $142.7 million, up 14.27% from the prior year.
  • Operating Expenses came in at -$27.4 million for Q1 2026 at Valneva SE, down from $246.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $246.6 million in Q4 2025 to a low of -$44.2 million in Q2 2022.
  • The 5-year median for Operating Expenses is -$27.4 million (2026), against an average of $28.3 million.
  • Peak annual rise in Operating Expenses reached 46.65% in 2022, while the deepest fall reached 42.68% in 2022.
  • Valneva SE's Operating Expenses stood at $242.5 million in 2022, then slipped by 22.88% to $187.0 million in 2023, then increased by 13.17% to $211.6 million in 2024, then gained by 16.56% to $246.6 million in 2025, then plunged by 111.1% to -$27.4 million in 2026.
  • The last three Operating Expenses figures came in at -$27.4 million (Q1 2026), $246.6 million (Q4 2025), and -$44.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 4.33 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 32.68 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 2.97 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -138.30 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 15.76 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -3.82 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 574,669.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.85 Bn
9 Abivax 94.26 Bn 94.26 Bn - -67.40 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -27.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -27.38 Mn
Dec 31, 2025 246.64 Mn
Sep 30, 2025 -44.16 Mn
Jun 30, 2025 -31.19 Mn
Mar 31, 2025 -25.16 Mn
Dec 31, 2024 211.60 Mn
Sep 30, 2024 -31.40 Mn
Jun 30, 2024 -30.88 Mn
Mar 31, 2024 -26.94 Mn
Dec 31, 2023 186.98 Mn
Sep 30, 2023 -30.93 Mn
Jun 30, 2023 -26.98 Mn
Mar 31, 2023 -25.87 Mn
Dec 31, 2022 242.46 Mn
Sep 30, 2022 -30.99 Mn
Jun 30, 2022 -44.23 Mn
Mar 31, 2022 -29.70 Mn
Dec 31, 2021 423.03 Mn
Sep 30, 2021 -58.09 Mn
Jun 30, 2021 -74.54 Mn